These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37448353)
1. Sodium Oxybate in Alcohol-Responsive Essential Tremor of Voice: An Open-Label Phase II Study. O'Flynn LC; Frucht SJ; Simonyan K Mov Disord; 2023 Oct; 38(10):1936-1944. PubMed ID: 37448353 [TBL] [Abstract][Full Text] [Related]
2. Neural Representations of the Voice Tremor Spectrum. de Lima Xavier L; Simonyan K Mov Disord; 2020 Dec; 35(12):2290-2300. PubMed ID: 32976662 [TBL] [Abstract][Full Text] [Related]
3. An open-label study of sodium oxybate in Spasmodic dysphonia. Rumbach AF; Blitzer A; Frucht SJ; Simonyan K Laryngoscope; 2017 Jun; 127(6):1402-1407. PubMed ID: 27808415 [TBL] [Abstract][Full Text] [Related]
4. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Frucht SJ; Bordelon Y; Houghton WH; Reardan D Mov Disord; 2005 Oct; 20(10):1330-7. PubMed ID: 15986420 [TBL] [Abstract][Full Text] [Related]
5. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Frucht SJ; Houghton WC; Bordelon Y; Greene PE; Louis ED Neurology; 2005 Dec; 65(12):1967-9. PubMed ID: 16382538 [TBL] [Abstract][Full Text] [Related]
9. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation. Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321 [TBL] [Abstract][Full Text] [Related]
10. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348 [TBL] [Abstract][Full Text] [Related]
11. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Mansukhani MP; Kotagal S Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591 [TBL] [Abstract][Full Text] [Related]
12. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients. Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia. Morse AM; Dauvilliers Y; Arnulf I; Thorpy MJ; Foldvary-Schaefer N; Chandler P; Chen A; Hickey L; Black J; Bogan RK J Clin Sleep Med; 2023 Oct; 19(10):1811-1822. PubMed ID: 37409509 [TBL] [Abstract][Full Text] [Related]
14. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial. Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733 [TBL] [Abstract][Full Text] [Related]
15. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Murali H; Kotagal S Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670 [TBL] [Abstract][Full Text] [Related]
16. An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor. Nahab FB; Wittevrongel L; Ippolito D; Toro C; Grimes GJ; Starling J; Potti G; Haubenberger D; Bowen D; Buchwald P; Dong C; Kalowitz D; Hallett M Neurotherapeutics; 2011 Oct; 8(4):753-62. PubMed ID: 21594724 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level. van den Brink W; Addolorato G; Aubin HJ; Benyamina A; Caputo F; Dematteis M; Gual A; Lesch OM; Mann K; Maremmani I; Nutt D; Paille F; Perney P; Rehm J; Reynaud M; Simon N; Söderpalm B; Sommer WH; Walter H; Spanagel R Addict Biol; 2018 Jul; 23(4):969-986. PubMed ID: 30043457 [TBL] [Abstract][Full Text] [Related]
18. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series. Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331 [TBL] [Abstract][Full Text] [Related]